Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christoph Schmutte is active.

Publication


Featured researches published by Christoph Schmutte.


Journal of Biological Chemistry | 1996

Structure and Characterization of the Human Tissue Inhibitor of Metalloproteinases-2 Gene

Khalil Hammani; Andrew Blakis; Delmore Morsette; Anne M. Bowcock; Christoph Schmutte; Patrick Henriet; Yves A. DeClerck

We report here the characterization of the human tissue inhibitor of metalloproteinases-2 (TIMP-2) gene. The gene is 83 kilobase pairs (kb) long with exon-intron splicing sites located in preserved positions among the three members of the TIMP family. A 2.6-kb genomic DNA fragment flanking the 5′-end of the gene contains several regulatory elements including five Sp1, two AP-2, one AP-1, and three PEA-3 binding sites. Despite the presence of a complete AP-1 consensus at position −281, the promoter did not respond to 12-O-tetradecanoylphorbol-13-acetate treatment. However, 12-O-tetradecanoylphorbol-13-acetate response was generated by insertion of a similar AP-1 consensus at position −71, indicating the importance of the positioning of this motif. The promoter contains a typical CpG island; however, methylation of this island did not seem to influence gene expression. Analysis of the 3′-end of the gene revealed that the two mRNAs for TIMP-2 (1.2 and 3.8 kb) differ by the selection of their polyadenylation signal sites, but selection of these sites does not affect RNA stability. In summary, the TIMP-2 gene has several features observed in housekeeping genes, and differs significantly from TIMP-1 and TIMP-3 genes. These differences are likely to explain the specific roles that these inhibitors play in the regulation of matrix metalloproteinases.


Cancer Biology & Therapy | 2002

DNA repair and tumorigenesis: lessons from hereditary cancer syndromes.

Christopher D. Heinen; Christoph Schmutte; Richard Fishel

The discovery that alterations of the DNA mismatch repair system (MMR) were linked to the common human cancer susceptibility syndrome hereditary nonpolyposis colon cancer (HNPCC) resulted in the declaration of a third class of genes involved in tumor development. In addition to oncogenes and tumor suppressors, alterations of DNA repair genes involved in maintaining genomic stability were found to be a clear cause of tum the level of the single nucleotides or chromosomes. This observation suggested that the establishment of genomic instability, termed the Mutator Phenotype, was an important aspect of tumor development.1,2 Since the initial identification of the human MutS homolog hMSH2 nearly a decade ago,3,4 more links have been described between human cancers and genes involved in maintaining genomic stability. Work in recent years has revealed that DNA repair proteins may also function in signaling pathways that provoke cell cycle arrest and apoptosis. This review will focus on the genetic and biochemical functions of DNA repair genes linked to hereditary cancer predisposition characterized by genomic instability (Table 1). Interestingly, the protein products of these genes have been directly or indirectly linked to the DNA damage-induce cell cycle arrest and apoptosis. We conclude that a robust connection between DNA repair proteins and damage-induced apoptosis may be as important for tumorigenesis as their role in maintaining genome stability. Key Words: DNA repair, Cancer, Apoptosis, Cell cycle, Checkpoints


Journal of Biological Chemistry | 2008

hMSH4-hMSH5 Adenosine Nucleotide Processing and Interactions with Homologous Recombination Machinery

Timothy Snowden; Kang-Sup Shim; Christoph Schmutte; Samir Acharya; Richard Fishel

We have previously demonstrated that the human heterodimeric meiosis-specific MutS homologs, hMSH4-hMSH5, bind uniquely to a Holliday Junction and its developmental progenitor (Snowden, T., Acharya, S., Butz, C., Berardini, M., and Fishel, R. (2004) Mol. Cell 15, 437–451). ATP binding by hMSH4-hMSH5 resulted in the formation of a sliding clamp that dissociated from the Holliday Junction crossover region embracing two duplex DNA arms. The loading of multiple hMSH4-hMSH5 sliding clamps was anticipated to stabilize the interaction between parental chromosomes during meiosis double-stranded break repair. Here we have identified the interaction region between the individual subunits of hMSH4-hMSH5 that are likely involved in clamp formation and show that each subunit of the heterodimer binds ATP. We have determined that ADP→ATP exchange is uniquely provoked by Holliday Junction recognition. Moreover, the hydrolysis of ATP by hMSH4-hMSH5 appears to occur after the complex transits the open ends of model Holliday Junction oligonucleotides. Finally, we have identified several components of the double-stranded break repair machinery that strongly interact with hMSH4-hMSH5. These results further underline the function(s) and interactors of hMSH4-hMSH5 that ensure accurate chromosomal repair and segregation during meiosis.


Cancer Biology & Therapy | 2009

Evidence that hMLH3 functions primarily in meiosis and in hMSH2-hMSH3 mismatch repair

Nicole Charbonneau; Ravindra Amunugama; Christoph Schmutte; Kristine E. Yoder; Richard Fishel

The MutS (MSH) and MutL (MLH) homologs are conserved proteins that function in mismatch repair (MMR) and meiosis. We examined mRNA and protein expression of hMLH3 compared to other human MSH and MLH in a panel of human tissues and the HeLa cell line. Quantitative PCR suggests that MSH and MLH transcripts are expressed ubiquitously. hMLH3 mRNA is present at low levels in numerous tissues. Protein expression appears to correlate with a threshold of mRNA expression with hMLH3 present at high levels in testis. In addition, we have found and mapped interactions between hMLH1 and hMLH3 with hMSH3. These data are consistent with yeast studies and suggest a role for hMLH3 in meiosis as well as hMSH2-hMSH3 repair processes and little if any role in Hereditary Non-Polyposis Colorectal Cancer (HNPCC).


Cancer Research | 1994

Two Molecular Pathways to Transitional Cell Carcinoma of the Bladder

Charles H. Spruck; Petra F. Ohneseit; Mirella Gonzalez-Zulueta; David Esrig; Noriomi Miyao; Yvonne C. Tsai; Seth P. Lerner; Christoph Schmutte; Allen S. Yang; Richard J. Cote; Louis Dubeau; Peter W. Nichols; Gregers G. Hermann; Kenneth Steven; Thomas Horn; Donald G. Skinner; Peter A. Jones


Cancer Research | 1996

Mechanisms for the Involvement of DNA Methylation in Colon Carcinogenesis

Christoph Schmutte; Allen S. Yang; TuDung T. Nguyen; Robert W. Beart; Peter A. Jones


Journal of Biological Chemistry | 2004

hXRCC2 Enhances ADP/ATP Processing and Strand Exchange by hRAD51

Kang Sup Shim; Christoph Schmutte; Gregory Tombline; Christopher D. Heinen; Richard Fishel


Carcinogenesis | 1994

Mutagenicity of nitric oxide is not caused by deamination of cytosine or 5-methylcytosine in double-stranded DNA

Christoph Schmutte; William M. Rideout; Jiang-Cheng Shen; Peter A. Jones


DNA Repair | 2006

Defining the salt effect on human RAD51 activities

Kang-Sup Shim; Christoph Schmutte; Kristine E. Yoder; Richard Fishel


Nucleic Acids Research | 1995

A mutant Hpall methyltransferase functions as a mutator enzyme

Jiang-Cheng Shen; Jean-Marc Zingg; Allen S. Yang; Christoph Schmutte; Peter A. Jones

Collaboration


Dive into the Christoph Schmutte's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Christopher D. Heinen

University of Connecticut Health Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Allen S. Yang

University of Southern California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jiang-Cheng Shen

University of Southern California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrew Blakis

Children's Hospital Los Angeles

View shared research outputs
Researchain Logo
Decentralizing Knowledge